Clinical Trials Logo

Clinical Trial Summary

Adhesions are the most frequent complication of abdominopelvic surgery. They are internal scar tissues which form as a result of surgery which may abnormally join together what were once separate tissues and organs.

This study will assess the safety and usability of anti-adhesion agent (gel) when used after laparoscopic surgery.

The study will enroll 30 patients, (randomised 2:1) with safety primary endpoint (adverse events in ADBLOCK and surgery only group) assessed at 28 days


Clinical Trial Description

Title: Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological surgery

Design: Randomised controlled study to assess the safety, manageability and usability of ADBLOCK when used as an adjunct to laparoscopic surgery for the primary removal of ('virgin') myomas in women wishing to improve pregnancy outcomes.

Use of ADBLOCK will be assessed against laparoscopic surgery alone in 30 patients (randomised 2:1 ADBLOCK/surgery) with a pneumoperitoneum ≤90minutes.

Clinical Site Locations:

- Oldenburg, Germany

- Neuss, Germany

- Berlin, Germany

Patient Population: Women who have not completed their family planning and who are undergoing primary ('virgin') laparoscopic myomectomy with an aim to improve pregnancy outcomes. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01745432
Study type Interventional
Source Terumo Europe N.V.
Contact
Status Completed
Phase Phase 1
Start date August 2012
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT01048931 - Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Phase 3
Completed NCT00755755 - PGL4001 Versus Placebo in Uterine Myomas Phase 3
Completed NCT01861015 - Vasopressin Versus Epinephrine in Myomectomy Phase 3
Terminated NCT01858454 - Hand-assisted Laparoscopic Surgery (HALS) for Myomectomy Phase 3
Completed NCT00874029 - Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids N/A
Completed NCT00743080 - Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators Phase 4
Recruiting NCT04400942 - Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy
Completed NCT00740831 - PGL4001 Versus GnRH-agonist in Uterine Myomas Phase 3